TABLE 2.
Comparisons of brain pathology findings based on SARS‐CoV‐2 RNA in COVID‐19 patients
| Brain pathology findings | SARS‐CoV−2 RNA | p value | ||
|---|---|---|---|---|
| Yes | No | |||
| Edema | Yes | 26/64 (40.6%) | 38/64 (59.4%) | 0.663 |
| No | 38/86 (44.2%) | 48/86 (55.8%) | ||
| Hypoxic‐ischemic lesions | Yes | 39/86 (45.3%) | 47/86 (54.7%) | 0.951 |
| No | 35/78 (44.9%) | 43/78 (55.1%) | ||
| Hemorrhagic lesions | Yes | 14/35 (40.0%) | 21/35 (60.0%) | 0.465 |
| No | 61/130 (46.9%) | 69/130 (53.1%) | ||
| Microgliosis | Yes | 36/90 (40.0%) | 54/90 (60.0%) | 0.146 |
| No | 38/74 (51.4%) | 36/74 (48.6%) | ||
| Astrogliosis | Yes | 35/88 (39.8%) | 53/88 (60.2%) | 0.161 |
| No | 39/77 (50.6%) | 38/77 (49.4%) | ||
| Inflammatory infiltrates | Yes | 34/86 (39.5%) | 52/86 (60.5%) | 0.131 |
| No | 40/78 (51.3%) | 38/78 (48.7%) | ||
Data are reported as number of patients (percent). p values were obtained using the Pearson χ2 test.